Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Bernard V. North"'
Autor:
Anne Lincoln, Sally Benton, Carolyn Piggott, Bernard V. North, Jane Rigney, Caroline Young, Philip Quirke, Peter Sasieni, Kevin J. Monahan
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Lynch Syndrome (LS) is an inherited cancer predisposition syndrome defined by pathogenic variants in the mismatch repair (MMR) or EPCAM genes. In the United Kingdom, people with LS are advised to undergo biennial colonoscopy from
Externí odkaz:
https://doaj.org/article/a5fbf90ce3404c64a3389b319ac14bc4
Autor:
Sheeba Irshad, Adrian C. Hayday, Katie J. Doores, Timothy Tree, Bernard V. North, Piers Patten, Austin Kulasekararaj, Jennifer Vidler, Ashwini Kurshan, Esme Carpenter, Helen Kakkassery, Charalampos Gousis, Emily Pollock, Celeste Arman, Thanussuyah Alaguthurai, Clara Domingo-Vila, Thomas Lechmere, Rosalind Graham, Duncan R. McKenzie
S3. Boosted serological responses and persistent T cell responses following SARS-CoV-2 vaccination dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87984dc47864236ff6c7cfc5aebe21f0
https://doi.org/10.1158/2767-9764.22545119
https://doi.org/10.1158/2767-9764.22545119
Autor:
Sheeba Irshad, Adrian C. Hayday, Katie J. Doores, Timothy Tree, Bernard V. North, Piers Patten, Austin Kulasekararaj, Jennifer Vidler, Ashwini Kurshan, Esme Carpenter, Helen Kakkassery, Charalampos Gousis, Emily Pollock, Celeste Arman, Thanussuyah Alaguthurai, Clara Domingo-Vila, Thomas Lechmere, Rosalind Graham, Duncan R. McKenzie
This study offers longitudinal insight into the impact of three SARS-CoV-2 vaccinations on humoral and cellular immunity in patients with solid cancers, patients with hematologic malignancies, and persons without cancer. For all cohorts, virus-neutra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da67bc3f40b9d272cc1281ab01b146c
https://doi.org/10.1158/2767-9764.c.6550859.v1
https://doi.org/10.1158/2767-9764.c.6550859.v1
Autor:
Sheeba Irshad, Adrian C. Hayday, Katie J. Doores, Timothy Tree, Bernard V. North, Piers Patten, Austin Kulasekararaj, Jennifer Vidler, Ashwini Kurshan, Esme Carpenter, Helen Kakkassery, Charalampos Gousis, Emily Pollock, Celeste Arman, Thanussuyah Alaguthurai, Clara Domingo-Vila, Thomas Lechmere, Rosalind Graham, Duncan R. McKenzie
Supplementary Table & Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36e8a1570ff8f1fca9548c7ea8d9017c
https://doi.org/10.1158/2767-9764.22545113.v1
https://doi.org/10.1158/2767-9764.22545113.v1
Autor:
Duncan R. McKenzie, Rosalind Graham, Thomas Lechmere, Clara Domingo-Vila, Thanussuyah Alaguthurai, Celeste Arman, Emily Pollock, Charalampos Gousis, Helen Kakkassery, Esme Carpenter, Ashwini Kurshan, Jennifer Vidler, Austin Kulasekararaj, Piers Patten, Bernard V. North, Timothy Tree, Katie J. Doores, Adrian C. Hayday, Sheeba Irshad
This study offers longitudinal insight into the impact of three SARS-CoV-2 vaccinations on humoral and cellular immunity in patients with solid cancers, patients with hematologic malignancies, and persons without cancer. For all cohorts, virus-neutra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4da4101c501b06c00f0420826020f8a9
Autor:
Jennifer Vidler, Shubhankar Sinha, Helen Kakkassery, Jack Cooper, Thanussuyah Alaguthurai, Thomas Hayday, Ana Montes, Yin Wu, Puay Ling Lee, Shraddha Kamdar, Leticia Monin, Muhammad Shamim Khan, Rosalind Graham, Daniel Davies, Maria Conde Poole, Miguel Muñoz-Ruiz, Adam Laing, Charlotte O'Brien-Gore, Sheeba Irshad, Sophie Papa, Anne Rigg, Elizabeth Harvey-Jones, Piers E.M. Patten, Magdalene Joseph, Paul Fields, Clara Domingo-Vila, Mark Harries, Francesca Di Rosa, Jeffrey Seow, Richard Davis, Adrian Hayday, Katie J. Doores, Duncan R. McKenzie, Isaac Francos Quijorna, Josephine Eum, Angela Swampillai, Timothy Tree, Bernard V. North, Liane Dupont, James Spicer, Michael H. Malim, Sultan Abdul-Jawad, Carl Graham, Irene del Molino del Barrio
Publikováno v:
Lancet oncology
22 (2021): 765–778. doi:10.1016/S1470-2045(21)00213-8
info:cnr-pdr/source/autori:Monin, Leticia; Laing, Adam G.; Muñoz-Ruiz, Miguel; McKenzie, Duncan R.; del Molino del Barrio, Irene; Alaguthurai, Thanussuyah; Domingo-Vila, Clara; Hayday, Thomas S.; Graham, Carl; Seow, Jeffrey; Abdul-Jawad, Sultan; Kamdar, Shraddha; Harvey-Jones, Elizabeth; Graham, Rosalind; Cooper, Jack; Khan, Muhammad; Vidler, Jennifer; Kakkassery, Helen; Sinha, Shubhankar; Davis, Richard; Dupont, Liane; Francos Quijorna, Isaac; O'Brien-Gore, Charlotte; Lee, Puay Ling; Eum, Josephine; Conde Poole, Maria; Joseph, Magdalene; Davies, Daniel; Wu, Yin; Swampillai, Angela; North, Bernard V.; Montes, Ana; Harries, Mark; Rigg, Anne; Spicer, James; Malim, Michael H.; Fields, Paul; Patten, Piers; Di Rosa, Francesca; Papa, Sophie; Tree, Timothy; Doores, Katie J.; Hayday, Adrian C.; Irshad, Sheeba/titolo:Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study/doi:10.1016%2FS1470-2045(21)00213-8/rivista:Lancet oncology (Print)/anno:2021/pagina_da:765/pagina_a:778/intervallo_pagine:765–778/volume:22
The Lancet. Oncology
22 (2021): 765–778. doi:10.1016/S1470-2045(21)00213-8
info:cnr-pdr/source/autori:Monin, Leticia; Laing, Adam G.; Muñoz-Ruiz, Miguel; McKenzie, Duncan R.; del Molino del Barrio, Irene; Alaguthurai, Thanussuyah; Domingo-Vila, Clara; Hayday, Thomas S.; Graham, Carl; Seow, Jeffrey; Abdul-Jawad, Sultan; Kamdar, Shraddha; Harvey-Jones, Elizabeth; Graham, Rosalind; Cooper, Jack; Khan, Muhammad; Vidler, Jennifer; Kakkassery, Helen; Sinha, Shubhankar; Davis, Richard; Dupont, Liane; Francos Quijorna, Isaac; O'Brien-Gore, Charlotte; Lee, Puay Ling; Eum, Josephine; Conde Poole, Maria; Joseph, Magdalene; Davies, Daniel; Wu, Yin; Swampillai, Angela; North, Bernard V.; Montes, Ana; Harries, Mark; Rigg, Anne; Spicer, James; Malim, Michael H.; Fields, Paul; Patten, Piers; Di Rosa, Francesca; Papa, Sophie; Tree, Timothy; Doores, Katie J.; Hayday, Adrian C.; Irshad, Sheeba/titolo:Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study/doi:10.1016%2FS1470-2045(21)00213-8/rivista:Lancet oncology (Print)/anno:2021/pagina_da:765/pagina_a:778/intervallo_pagine:765–778/volume:22
The Lancet. Oncology
Summary Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (Pfizer–BioNTech) vaccine in patients with cancer. Methods For t
Autor:
Timothy Tree, Bernard V. North, Sophie Papa, K. Owczarczyk, Sultan Abdul-Jawad, Hartmut Kristeleit, Kamila Sychowska, Piers E.M. Patten, Sheeba Irshad, Clara Domingo-Vila, Catherine Tremain, Jennifer Vidler, Paul Fields, Thomas Lechmere, Emily Pollock, Rosalind Graham, Carl Graham, Jeffrey Seow, Leticia Monin, Thanussuyah Alaguthurai, Miguel Muñoz-Ruiz, Michael H. Malim, Jack Cooper, Katie J. Doores, Charalampos Gousis, Adrian Hayday, Duncan R. McKenzie, Angela Swampillai
Publikováno v:
Cancer Cell
Autor:
Caryn S Ross-Innes, Irene Debiram-Beecham, Maria O'Donovan, Elaine Walker, Sibu Varghese, Pierre Lao-Sirieix, Laurence Lovat, Michael Griffin, Krish Ragunath, Rehan Haidry, Sarmed S Sami, Philip Kaye, Marco Novelli, Babett Disep, Richard Ostler, Benoit Aigret, Bernard V North, Pradeep Bhandari, Adam Haycock, Danielle Morris, Stephen Attwood, Anjan Dhar, Colin Rees, Matthew D D Rutter, Peter D Sasieni, Rebecca C Fitzgerald, BEST2 Study Group
Publikováno v:
PLoS Medicine, Vol 12, Iss 1, p e1001780 (2015)
BackgroundBarrett's esophagus (BE) is a commonly undiagnosed condition that predisposes to esophageal adenocarcinoma. Routine endoscopic screening for BE is not recommended because of the burden this would impose on the health care system. The object
Externí odkaz:
https://doaj.org/article/e39228c75d7e4b74ba218da0be63e29f
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Cancer
BMC Cancer
Background A key challenge in phase I trials is maintaining rapid escalation in order to avoid exposing too many patients to sub-therapeutic doses, while preserving safety by limiting the frequency of toxic events. Traditional rule-based designs requ
The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis
Autor:
Claude Chelala, Stefano Pirrò, Daniel M. Berney, Emanuela Gadaleta, Sakunthala C. Kudahetti, Yanan Zhu, Guoping Ren, Yong-Jie Lu, Xueying Mao, Bernard V. North, Jun Wang, Jacek Marzec, Luis Beltran, Elzbieta Stankiewicz, Amar Ahmad, Solene-Florence Kammerer-Jacquet, Helen Ross-Adams
Publikováno v:
Cancers
Cancers, Vol 13, Iss 345, p 345 (2021)
Volume 13
Issue 2
Cancers, Vol 13, Iss 345, p 345 (2021)
Volume 13
Issue 2
Simple Summary There is a tremendous amount of gene expression information available for prostate cancer, but very few tools exist to combine the disparate datasets generated across sample types and technical platforms. We present a method of integra